In a report released today, Kevin Steinke from Barrington maintained a Buy rating on Cross Country Healthcare (NASDAQ: CCRN), with a price target of $13. The company’s shares opened today at $9.07.
Steinke commented:
“We are lowering our 12-month price target to $13 (from $15), which assumes an EV/NTM EBITDA multiple of 10x one year from now and still represents 44% potential upside. Our investment rating is OUTPERFORM.”
According to TipRanks.com, Steinke is a 4-star analyst with an average return of 7.3% and a 68.6% success rate. Steinke covers the Services sector, focusing on stocks such as Echo Global Logistics, Heidrick & Struggles, and Navigant Consulting.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Cross Country Healthcare with a $12 average price target.
See today’s analyst top recommended stocks >>
Cross Country Healthcare’s market cap is currently $322.2M and has a P/E ratio of 8.62. The company has a Price to Book ratio of 1.36.
Based on the recent corporate insider activity of 49 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of CCRN in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Cross Country Healthcare, Inc. engages in the provision of healthcare staffing and workforce management solutions. It operates through the following segments: Nurse and Allied Staffing, Physician Staffing, and Other Human Capital Management Services.
